Literature DB >> 7767491

Inherited prion diseases and transmission to rodents.

J Tateishi1, T Kitamoto.   

Abstract

Clinico-pathological phenotypes of patients with prion diseases were compared with their PrP genotypes and transmission rate to mice. Sporadic and iatrogenic CJD patients without mutation and familial CJD patients with E200K showed uniform clinico-pathological features, synaptic-type deposition of PrPCJD and high rate of transmission of the disease to mice. GSS patients with P102L showed long duration of ataxia, numerous plaques in cerebellar cortex and transmitted the disease to mice in only one third of inoculated cases. Other mutations such as P105L, A117V, Y145stop, V180I, M232R and various insertions have particular phenotypes, distinct distribution patterns of PrPCJD, and untransmitted or inconclusive transmission to mice. Polymorphism at codon 129 may modify the phenotypes and transmission rate to mice. Therefore, prion diseases have a wide range from infectious disease to non-infectious, hereditary metabolic disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7767491     DOI: 10.1111/j.1750-3639.1995.tb00577.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  39 in total

1.  Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel.

Authors:  Soo Jung Kim; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

2.  Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils.

Authors:  Eric M Jones; Bo Wu; Krystyna Surewicz; Philippe S Nadaud; Jonathan J Helmus; Shugui Chen; Christopher P Jaroniec; Witold K Surewicz
Journal:  J Biol Chem       Date:  2011-10-15       Impact factor: 5.157

3.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

4.  Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice.

Authors:  Karah E Nazor; Franziska Kuhn; Tanya Seward; Mike Green; Daniel Zwald; Mario Pürro; Jaqueline Schmid; Karin Biffiger; Aisling M Power; Bruno Oesch; Alex J Raeber; Glenn C Telling
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

5.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

6.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

Review 7.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

Review 8.  Prion protein biosynthesis and its emerging role in neurodegeneration.

Authors:  Oishee Chakrabarti; Aarthi Ashok; Ramanujan S Hegde
Journal:  Trends Biochem Sci       Date:  2009-05-15       Impact factor: 13.807

Review 9.  Molecular advances in understanding inherited prion diseases.

Authors:  David R Brown
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

10.  Transmissibility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression and donor prion genotype.

Authors:  Jean-Noël Arsac; Dominique Bétemps; Eric Morignat; Cécile Féraudet; Anna Bencsik; Denise Aubert; Jacques Grassi; Thierry Baron
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.